While the treatment of spider, reticular and varicose veins using sclerotherapy has been a standard practice for many years, tumescent enhanced sclerotherapy has been developed as an office-based technique that takes traditional sclerotherapy a step further by applying a...
Results of a randomised controlled trial conducted at Imperial College, London, UK, have shown that the application of compression stockings is associated with a significant reduction in pain during the first few days following intervention. In addition, it was...
Based on the results of a retrospective, single-centre cohort study conducted at The RANE Center, St Dominic’s Memorial Hospital (Jackson, Mississippi, USA), the importance of intravascular ultrasound (IVUS) for identifying the location and severity of stenotic lesions in the...
Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last month, the first two stroke patients were treated using the same platform. The company received...
Additional ultrasound-accelerated catheter-directed thrombolysis does not lower the risk of post-thrombotic syndrome in patients with acute iliofemoral deep-vein thrombosis (DVT), according to findings of the CAVA trial presented at the International Union of Phlebology chapter meeting (UIP 2019; 25–27...
There are “significant limitations” to the use of duplex ultrasound for the initial evaluation of patients with suspected subclavian vein (SCV) thrombosis, according to the findings of a retrospective, single-centre review published in the Journal of Vascular Surgery: Venous...
Writing to members of the American Venous Forum (AVF), president Brajesh K Lal (Baltimore, USA), has revealed that the AVF has established a partnership with the C-TRACT study, a randomised controlled trial funded by the National Institutes of Health....
Long-term evaluation of superficial venous reflux below the knee, in patients who received invasive treatment for varicose veins, has found that both radiofrequency ablation (RFA) and open surgery achieve "acceptable and comparable results" in the elimination of reflux in...
In the treatment of reticular veins of the lower extremities, using polidocanol foam, it has been found that both a 1:2 ratio and 1:4 ratio of polidocanol to air demonstrate similar levels of efficacy and safety. According to presenter...
Findings of a recent study on whether a pathologic perforator can predict the presence of an ipsilateral central venous stenosis, as presented at the annual meeting of the American Vein and Lymphatic Society (AVLS; 7–10 November 2019, Arizona, USA),...
Implementation of an evidence-based pathway for leg ulcer care in community nursing has resulted in a significant reduction in healing times, according to research conducted by the Manchester University NHS Foundation Trust, Manchester, UK. Although quality of life scores...
John-Kaufman-profile

John Kaufman

As course director of The VEINS at VIVA 2019 (2–4 November, Las Vegas, USA), John Kaufman tells Venous News how the field of interventional radiology (IR) has transformed over the years and highlights key areas of innovation to look...
Miles D White will be stepping down, after 21 years, as CEO of Abbott on 31 March 2020. According to a press release, White’s tenure is the second longest for a non-founder in today’s S&P 100; he will remain...
Reflux of the lateral subdermic plexus—varicose veins which appear on the outside of the thigh and calf—could be closely related to the symptoms of restless leg syndrome and night-time cramping, according to a review conducted on prospective symptom tracking...
Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to affect short-term and long-term outcomes such as cardiopulmonary health after PE needs “better characterisation”, Akhilesh...
David J. Dexter, (Sentara Healthcare, Norfolk, VA, USA), principal investigator of the CLOUT registry using the ClotTriever Mechanical Thrombectomy System (Inari Medical) for treatment of acute and chronic lower extremity DVT, presented the initial results for the first 50...
 Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about his current take on the open vein hypothesis and more. Vedantham reflects on...
In this issue of Venous News: Future trials on DVT management "have to focus on technical success" Foam "has not been established as superior" to liquid sclerotherapy Manj Gohel: A look at new preliminary guidelines for SVT Anelise Rodrigues: Augmented reality...
In this issue of Venous News: Future trials on DVT management "have to focus on technical success" Foam "has not been established as superior" to liquid sclerotherapy Manj Gohel: A look at new preliminary guidelines for SVT Anelise Rodrigues: Augmented reality...
Inari Medical has announced the presentation of early outcomes from the ClotTriever Outcomes Registry (CLOUT) using the ClotTriever Mechanical Thrombectomy System for treatment of acute and chronic lower extremity deep vein thrombosis (DVT). Initial results for the first 50...
It has been found by the EXTRACT-PE trial, a multicentre investigation conducted under an investigational device exemption (IDE) from the US Food and Drug Administration (FDA), that aspiration thrombectomy for acute pulmonary embolism (PE) with the Indigo Aspiration System...
A Philadelphia jury has awarded more than US$33 million to a woman who was injured as a result of a defectively designed inferior vena cava (IVC) filter. The trial was overseen by Philadelphia Judge Michael Erdos. The litigation focused on...
Analysing the results of a retrospective, single-centre cohort study conducted at Guys and St Thomas’ Hospital, London, UK, Anna Pouncey (Guys and St Thomas’ Hospital, London, UK) emphasised that over 50% of cases included in the investigation could have...
Speaking at the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2019; 7–11 September, Barcelona, Spain), Stephen Black (Guys and St Thomas’ Hospital, London, UK) emphasised that “ATTRACT and CAVA are not the end of...
It has been found that the application of dehydrated human amnion and chorion allografts (dHACA) results in a better venous leg ulcer (VLU) healing rate than the use of standard multilayer compression therapy, following a randomised controlled study comparing...
Current classification tools for the diagnosis of chronic venous disease, including acute deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS), include “redundant” elements that are unimportant to patients, according to an address delivered by Mark Meissner (Seattle, USA) at...
Venarum Medical has announced that it has received a mentorship grant in further support of its awarded Phase II SBIR Grant “EVVS: EndoVenous Valve System”, which is currently underway. Under its Phase II work, Venarum proposes to verify the preclinical...
A report titled ‘Venous Leg Ulcers: A Silent Crisis’ has been published by the All-Party Parliamentary Group on Vascular and Venous Disease (VVAPPG) at an event held at the Palace of Westminster, highlighting the opportunities available to help thousands...
At the European Society of Vascular Surgery annual meeting (ESVS 2019; ­24­­-27 September, Hamburg, Germany), preliminary venous thrombosis guidelines were presented for the first time. Chaired by Stavros Kakkos (Patras, Greece) and Manj Gohel (Cambridge University Hospitals, Cambridge, UK),...
Indocyanine green dye (ICG) fluorescence lymphography represents a suitable method of providing information on the effectiveness of intermittent pneumatic compression (IPC) during the treatment of leg oedema (an excess of fluid around the limb), according to a study conducted...
STARmed has announced that it has obtained CE Mark approval for VENISTAR, an "innovatively designed" electrode that uses radiofrequency energy to treat patients with damaged veins. According to a statement, this minimally invasive electrode provides physicians with the ability...
PolarityTE, a company specialised in regenerative tissue products and biomaterials, has announced findings from an open-label, single-arm pilot study, which examined the impact of SkinTE in closing venous stasis leg ulcers (VLUs) following the failure of conventional treatments. The clinical outcomes...
A pilot evaluation of a new multilayer wound dressing has confirmed its efficacy for transporting exudate containing toxic matrix metalloproteases (MMPs) away from chronic venous leg ulcers (VLUs). Conducted by Oscar M Alvarez (University Hospital; Rutgers New Jersey Medical...
UK-based Sky Medical Technology has received US Food and Drug Administration (FDA) 510(k) clearance for its "geko" device for stimulation of the calf muscles to prevent venous thrombosis in non-surgical patients at risk for venous thromboembolism (VTE). This adds...
Speaking at the International Union of Phlebology chapter meeting (UIP 2019; 25–27 August, Krakow, Poland), Neil Khilnani (New York, USA) underlined that the current literature on sclerotherapy, in addition to guidelines from the European Consensus and American Society for...
Kurosh Parsi profile

Kurosh Parsi

Kurosh Parsi, incoming president of the International Union of Phlebology, or Union Internationale de Phlebologie (UIP), is an Australian dermatologist, phlebologist and vascular anomalies specialist who pioneered catheter-guided and tumescent-assisted sclerotherapy. With his broad range of expertise and varied...
Clinical data presented at the 2019 European Cardio-Thoracic Surgery (EACTS) annual meeting (3-5 October, Lisbon, Portugal), from two prospective trials of the VEST external stent for vein grafts during coronary artery bypass surgery (CABG), showed low major adverse cardiac...
At the 2019 Transcatheter Cardiovascular Therapeutics (TCT) meeting (25–29 September, San Francisco, USA), InterVene won the TCT-Shark Tank Innovation Competition for its novel endovenous system (BlueLeaf) for forming valves in patients with deep vein reflux and/or chronic venous insufficiency. The award, which...
In this issue of Venous News: SUPER trial demonstrates benefits of intermittent pneumatic compression "Fascinating vision" of non-invasive varicose vein treatment Oliver Lyons: Pharmacotherapy for lymphoedema Efthymios Avgerinos: SUNSET sPE interim outcomes Profile: Kurosh Parsi
In this issue of Venous News: SUPER trial demonstrates benefits of intermittent pneumatic compression "Fascinating vision" of non-invasive varicose vein treatment Oliver Lyons: Pharmacotherapy for lymphoedema Efthymios Avgerinos: SUNSET sPE interim outcomes Profile: Kurosh Parsi
Like many other industries, the shape of healthcare and medicine is being transformed by the emergence of new technologies. Phlebology, as Anelise Rodrigues (Culabá, Brazil) explains, is no different. While there are still concerns with the potential limitations and...
Laser crossectomy of the GSV has been established as a more effective method of preventing secondary anterior accessory great saphenous vein (AAGSV) reflux than treatment modalities which leave stumps. As part of a randomised controlled study comparing the technique...
Bluegrass Vascular Technologies (Bluegrass Vascular) has announced the publication of positive results associated with the clinical use of the Surfacer Inside-Out access catheter system in the peer-reviewed Journal of Vascular Access (JVA). Results of an independent, single-centre study demonstrated successful use...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the publication of new real-world evidence which confirms that XARELTO (rivaroxaban) reduces the risk of recurrent venous thromboembolism (VTE) in patients who are morbidly obese, with effectiveness and safety...
 Sanjay Misra (Rochester, USA) talks to Interventional News about his research into whether stem cell therapy can help AVFs (arteriovenous fistulas) mature and also prevent venous stenosis. The pilot study with a small group of haemodialysis AVF patients led to “promising...
While compression therapy is of the treatment options for patients suffering with venous insufficiency and chronic wounds, this could also present benefits for healthy subjects. Following his presentation at the International Union of Phlebology chapter meeting (UIP 2019; 25–27...
There is no significant difference in pain and recanalisation for patients undergoing endovenous laser ablation (EVLA) at different power settings, according to the results of a new randomised controlled clinical trial. This investigation was conducted following a previous morphological...
Evidence from a recent study conducted by Imperial College London, UK has further demonstrated that the Villalta scoring system is not disease-specific and correlates with other tools for measuring venous outcomes. The results of the study have implications for...
PIUR Imaging has launched a portable version of its tomographic ultrasound system to the European market. The new CE-marked PIUR tUS Infinity is a small, wireless version of its tomographic ultrasound solution that turns any standard ultrasound into a...
Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, following the end of the company’s current fiscal year. Also, the Medtronic Board of Directors has announced key leadership appointments as part of its multi-year, leadership...
 Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain. Dake said: “The 24-month results from the VERNACULAR trial using the BD Venovo stent show absolutely sustained benefit in...
Boehringer Ingelheim has announced the publication of primary analysis from RE-SPECT CVT, the first exploratory, prospective, randomised controlled study of a NOAC in patients with blood clots in the veins or venous sinuses of the brain. The trial investigated...
An updated guideline on the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer has been unveiled by the American Society of Clinical Oncology (ASCO) in its Journal of Clinical Oncology. An expert panel convened by ASCO...
A study into the efficacy of early reflux elimination for venous leg ulcer (VLU) patients has revealed that the combination of ultrasound-guided foam sclerotherapy (UGFS) only, and a hybrid method of endovenous laser treatment (EVLT) with UGFS, could present...
A private equity firm, Palatine (Manchester, UK), has announced that it has made a “significant investment” into a UK centre—Veincentre—that provides endovenous laser ablation (EVLA) for the management of varicose veins.  The investment, according to Palatine, is the fourth...
Results from two open prospective trials have revealed that TLC-NOSF sucrose octasulphate dressing, with poly-absorbent fibres, represents an effective and safe treatment for the local management of leg ulcers. In addition, cost-effectiveness studies examining the economic impact of the...
While developing specific treatment for primary lymphoedema presents an “enormous” scientific challenge, secondary lymphoedema may prove an easier target, Oliver Lyons writes for Venous News. In this article, Lyons outlines what is currently known, and what to expect in...
Certain reflux patterns in patients with chronic venous disease can be associated with increased clinical severity and a lower quality of life, according to the results of a recent study conducted at Imperial College London, UK. As part of...
Thrombolex has announced the enrolment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir Endovascular Catheter for the treatment of submassive pulmonary embolism (PE). The device was designed to quickly and safely dissolve thrombus...
A member of the UK parliament has emphasised the need for a national wound care strategy during a recent debate in the House of Commons, highlighting that “diagnosis is difficult, but rapid diagnosis is absolutely essential”. Ann Clywd, MP...
 Karen Bauer (Toledo, USA) discusses the wound care limb salvage track at C3 which offered the “opportunity for clinicians from multiple disciplines to get together and talk about some really cutting-edge” topics. Bauer, a wound specialist, says that at the...
In her presentation at the Royal Society of Medicine Venous Forum (RSMVF; 17–19 June, London, UK), consultant vascular surgeon Emma Wilton (Oxford University Hospitals, Oxford, UK) outlined the important process for identifying which patients with leg ulceration require deep...
Endovenous laser ablation (EVLA) of perforating veins has been further established as an effective method of treating chronic venous ulcers in patients with diabetes mellitus, according to a new study conducted in Azerbaijan. Results of the study, which involved 42...
A recent study has concluded that patients with inherited or acquired thrombophilia should not be excluded from ilio-femoral venous stenting, Adam Gwozdz (St Thomas’ Hospital, London, UK) reported at the European Venous Forum (EVF; 27–29 June, Zurich, Switzerland). “By...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing paediatric patients (aged birth to 17 years) treated with rivaroxaban (brand name Xarelto) had a similar low risk of recurrent...
A US-based multicentre study has found that while chronic venous insufficiency is “primarily observed in white women”, there are other notable differences in the incidence and prevalence of disease severity and outcomes when comparing patients’ racial groups, with African...
Rabih Chaer (Pittsburgh, USA) talks to Venous News at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM; 12–15 June 2019, Washington, DC, USA)about the “need for dedicated venous stents” in the US in anticipation of the recently US FDA approved...
InterVene has announced it has raised US$15 million in a Series B financing round. The company’s BlueLeaf Endovenous Valve Formation System is the first catheter-based solution for deep venous reflux that does not require an implant. The system is designed to correct one...
The new West London Vascular and Interventional Centre at Northwick Park Hospital (Harrow, UK) has officially been declared open. As of the 25th June, 2019, patients who require vascular treatment will be able to benefit from the modern facilities...
Siemens Healthineers and Mentice AB have announced that they are collaborating to fully integrate Mentice’s VIST virtual patient into the Artis icono angiography system from Siemens Healthineers. According to a press release, the VIST virtual patient thus becomes a fully...
Catheter-directed thrombolysis improves outcomes and long-term cost efficiency for treatment of massive and submassive pulmonary embolism (PE), in comparison to systemic heparin administration. This was the conclusion of study investigators led by Patrick Kelly (Sanford Health, Sioux Falls, USA),...
The Standard vs ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism (SUNSET sPE) trial, is an ongoing randomised, head-to-head, single-blinded clinical trial comparing ultrasound-assisted thrombolysis to standard catheter-directed thrombolysis. While comparative data is not yet available, Efthymios "Makis" Avgerinos (University...
In this issue: - "Urgent action" is required to improve referral for venous ulcer patients - VenaSeal maintains safety and efficacy at extended five-year follow-up - Dominik Heim: The 20th European Venous Forum (EVF) - Raghu Kolluri: The role of elevated central venous...
In this issue: - "Urgent action" is required to improve referral for venous ulcer patients - VenaSeal maintains safety and efficacy at extended five-year follow-up - Dominik Heim: The 20th European Venous Forum (EVF) - Raghu Kolluri: The role of elevated central venous...
The TLC-NOSF (UrgoStart, Urgo Medical) advanced wound care dressing was recently recommended by the UK National Institute for Health and Care Excellence (NICE) for healing of venous and diabetic foot ulcers. Speaking at the European Wound Management Association annual...

Fedor Lurie

Fedor Lurie started his medical career in Ekaterinburg, Russia, on the east side of the Ural mountain chain. Now a long-time prominent figure in some of the largest venous and vascular societies in the USA, Lurie speaks to Venous...
Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly Bard) at CX 2019. Dubenec talks about how the Venovo stent – which comes in a...
The last two decades have seen a major revolution in the treatment of varicose veins and venous reflux disease—and we may be on the brink of the next big shift. This is what Mark S Whiteley writes for Venous...
 Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve. Edmonds...
A new study has found that intensive care unit patients with swine flu (H1N1) and acute respiratory distress syndrome (ARDS) were 33 times more likely to develop venous thromboembolism (VTE), unless prescribed with an anticoagulant when admitted. The findings were...
Vesper Medical, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced a US$37 million financing with Vensana Capital and Gilde Healthcare as lead investors. They were joined by existing investors New Enterprise Associates (NEA) and...
In this article for Venous News, Dominik Heim spoke to Michel Perrin and Bo Eklöf about the founding of the European Venous Forum (EVF; 27–29 June, Zürich, Switzerland), an international symposium for venous specialists that this year celebrated its...
Defining success in venous ulcer healing, and for all chronic wounds, remains a nebulous concept—with no consensus on what constitutes a successful outcome. Dave Bosanquet (Bristol, UK) outlined the difficulties at the Charing Cross Symposium (CX; 15–18 April, London,...
A new treatment modality is aiming to take the idea of minimally-invasive procedures to the next level for treatment of varicose veins and venous insufficiency. Alfred M Obermayer of the Institute of Functional Phlebosurgery, Karl Landsteiner Society in Vienna,...
Thrombolex has announced that the US Food and Drug Administration (FDA) has cleared the Bashir Endovascular Catheter (BEC) for the controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature, and the Bashir N-X Endovascular Catheter...
Inari Medical has announced the publication of its 106-patient prospective multicentre FlowTriever Mechanical Pulmonary Embolectomy (FLARE) study for the treatment of intermediate-risk pulmonary embolism (PE). The study was published in JACC: Cardiovascular Interventions. FLARE was conducted under the direction...
Boston Scientific has announced hat the US Food and Drug Administration (FDA) has approved the Vici venous stent system for the treatment of iliofemoral venous obstructive disease. Venous obstructive disease affects nearly 40% of the population in the USA and...
Also known as "Vein Specialists Sitting around Talking and Having Drinks," the VEIN Magazine Podcast with Steve Elias features real discussions on venous disease and treatment. Once a month, this podcast brings together leaders in the venous treatment world...
Prakash Saha (London, UK), speaking during the Venous and Lymphatic Challenges programme at CX (15–18 April, London, UK), outlined the three key steps to optimising treatment of acute deep vein thrombosis: identification, management, and surveillance. He added that the...
Raghu Kolluri gives an overview of elevated central venous pressure—a condition which Kolluri argues is elusive, underdiagnosed and in need of further examination in order to establish its role and relationship to chronic venous insufficiency. It is not uncommon to...
“A lot more bacteria than anticipated” have been discovered on wounds in a patient cohort consisting of 89% venous leg ulcers, and using fluorescence imaging proved superior for detecting infection in wounds. This was the conclusion of Tomas Serena (Warren,...
Despite what current guidelines denote, and in addition to the emergence of data supporting the early intervention of venous ulceration, Alun Davies (London, UK) put forward that the recommendations are consistently being ignored, and highlighted that: “Urgent action is...
The first-ever 60-month data on Medtronic’s VenaSeal closure system were presented on Tuesday, indicating that at five years, treatment with the cyanoacrylate adhesive for closure of diseased vein segments was not inferior to the alternative treatment arm of radiofrequency...
Speaking at the Charing Cross International Symposium (CX; 15–18 April, London, UK), Isaac Nyamekye (Worcester, UK) presented the results of the 3RF study, which compared three radiofrequency ablation systems (Venefit, RFITT, and EVRF). Nyamekye reported that compared with the...
A recent paper published by Hakan Duman (Recep Tayyip Erdoğan University, Rize, Turkey) and colleagues in the Journal of Vascular Surgery: Venous and Lymphatic Disorders has concluded that lower levels of bilirubin were significantly associated with venous thromboembolism (VTE),...
 Michael D Dake (Tucson, USA) presented results from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the treatment of iliac and femoral vein occlusions. At one year, the researchers found that the...
 Mahmood Razavi (Orange, USA) reported new data from a subanalysis of the VIRTUS trial, which set out to investigate the safety and efficacy of the Vici stent (Boston Scientific). The subanalysis forms part of the first prospective multicentre corelab...
Kasuo Miyake is a leader in Cryo-Laser and Cryo-Sclerotherapy (CLaCS) treatments for varicose veins. Based in Sāo Paulo, Brazil, Miyake heads the vein clinic founded by his late father, Hiroshi Miyake, a pioneer in the field of CLaCS and...
Healogics, a provider of advanced chronic wound care services in the USA, has announced they have added vein ablation to their in-house service offerings through a new programme called Healogics VeinCare. This programme allows the company to provide patients...
BD has announced that the US Food and Drug Administration (FDA) has granted premarket approval for the Venovo venous stent, the first stent indicated to treat iliofemoral venous occlusive disease. The Venovo venous stent is a flexible nitinol stent specifically...
The CASSINI trial found that treatment with rivaroxaban did not significantly reduce the incidence of thromboembolism or death caused by thromboembolism in high-risk ambulatory patients with cancer during the 180-day study period. However, during the study’s intervention period, there...
The commissioner of the US Food and Drug Administration (FDA), Scott Gottlieb, has unexpectedly resigned after serving just shy of two years in the post. Gottlieb announced his intention to stand down in a letter to Alex Azar II, the...
At the 2018 Vascular Societies’ Annual Scientific Meeting (VSASM; 27–29 November, Glasgow, UK), Bruce Campbell from Exeter Medical in Exeter, UK, who previously chaired National Institute for Health and Care Excellence (NICE) advisory committees for interventional procedures and medical...

Johann Chris Ragg

Johann Chris Ragg speaks to Venous News about the innovations he pioneered and the work that inspired his projects, as well as the challenges and benefits of running a private vascular clinic specialising in endovenous treatments. Ragg recounts his...
In this issue: New ATTRACT data show greater benefits of catheter-based therapy for iliofemoral DVT patients NICE aortic guidelines debate prompts scrutiny of venous guidelines and evidence gaps Thom Rooke: Avoiding sclerotherapy complications Profile: Johann Chris Ragg  

Venous News 9 – January 2019

In this issue: New ATTRACT data show greater benefits of catheter-based therapy for iliofemoral DVT patients NICE aortic guidelines debate prompts scrutiny of venous guidelines and evidence gaps Thom Rooke: Avoiding sclerotherapy complications Profile: Johann Chris Ragg  
The UK's National Institute of Health and Care Excellence (NICE) has published new guidance recommending UrgoStart wound dressings (Urgo Medical) for treatment of diabetic foot ulcers and venous leg ulcers. In a press release, Urgo Medical states that use...
The editors-in-chief of major cardiovascular journals—of both US and European societies—have come together to “sound the alarm” about the dangers of medical misinformation that has been disseminated through the internet, social media, and other platforms. They claim that this...
Philips launches its Azurion with FlexArm to aid patient imaging and positioning during image-guided procedures. During increasingly complex interventions, clinicians need to quickly and easily visualise critical anatomy and identify changes to the patient during the procedure. Azurion with FlexArm...
Medical device company Hancock Jaffe has announced the end-points for its upcoming VenoValve first-in-human study in Bogota, Colombia. Endpoints for the study will include improvements in reflux time, as well as three venous clinical measurement tools: the revised Venous...
Speaking at the Leipzig Interventional Course (LINC; 22–25 January, Leipzig, Germany), Katja Mühlberg of the University of Leipzig, Germany, called for an improvement in the evidence base around the role of compression in healing venous leg ulcers (VLU). Mühlberg...
New 12-month data from the VIRTUS trial demonstrates that patients who were treated with the Vici Venous Stent system (Boston Scientific) for iliac and femoral vein obstructions exhibited a high rate of patent, or open, target lesions. Primary safety and...
The US government shutdown means the country’s Food and Drug Administration (FDA) cannot accept new user fees, which means the agency cannot accept new medical product applications. FDA commissioner Scott Gottlieb took to Twitter to highlight agency employees who are...
The first-in-human case using the new deep vein thrombosis (DVT) device Vetex thrombectomy catheter (Vetex Medical) has recently been completed in a multicentre study. The device has the potential to reduce hospital stays and costs associated with DVT treatment,...
A single-centre experience using large, braided self-expanding stents for iliofemoral venous obstruction found "excellent" outcomes. Several useful techniques and pearls for improved outcomes are reported in the January edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders. Placement...
Merit Medical Systems, Inc. has announced that it has acquired substantially all of the assets of Vascular Insights, LLC, based in Quincy, USA. Vascular Insights’ primary assets are the ClariVein IC and ClariVein OC specialty infusion and occlusion catheter...
The study data were delivered in two presentations at VEITHsymposium (13–17 November, New York, USA) by Mark Adelman (NYU Langone Hosptial, New York, USA) and Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA). They explained that incompetent perforator veins are...
 An analysis of ATTRACT has recently been published in the journal Circulation, in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT patients with iliofemoral deep vein thrombosis (DVT). As a result of this, Venous News spoke to...
 Venous News arranged a roundtable with Sophie Renton (London, UK), Bruce Campbell (Exeter, UK) and Manj Gohel (Cambridge, UK), who called for more high quality, medium-to-long-term evidence to support the growing use of minimally invasive, but expensive, interventions for deep...
The members of the American College of Phlebology (ACP) have voted to change their name to the American Vein and Lymphatic Society (AVLS). The name change is a part of the Society’s mission and vision to provide advocacy efforts,...
A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous thrombosis (DVT) in whom pharmacomechanical catheter-directed thrombolysis (PCDT) was evaluated within the ATTRACT trial. The authors,...
 Kathleen Gibson (Bellevue, USA), one of the principal investigators of the SeCure trial, presented its results at the ACP 2018 annual congress. “More than closure rates, it is the quality of life findings from this trial that are important...
Inari Medical has announced the enrolment of the first patient in the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) using the company’s FlowTriever System for the treatment of pulmonary embolism (PE). FLASH is a 500-patient prospective, multicentre registry...
Results from the Phase 3 CASSINI study contributes new data on the use of oral anticoagulant rivaroxaban (brand name Xarelto, Johnson & Johnson) in the management and prevention of venous thromboembolism (VTE) in high-risk patients with cancer. The composite...
The world’s first bioconvertible IVC filter commercially offered in the USA (Sentry; from BTG) has been successfully implanted into the first patients outside of a clinical trial. The Sentry filter is designed to provide protection from pulmonary embolism for the...
In this issue: Strategies needed to address radiation exposures during venous procedures Nationwide study finds no significant difference between rivaroxaban and apixaban for VTE patients Profile: Ramesh Tripathi Una adderley: Choosing the right compression Alison Hopkins: Changing the narrative...
In this issue: Strategies needed to address radiation exposures during venous procedures Nationwide study finds no significant difference between rivaroxaban and apixaban for VTE patients Profile: Ramesh Tripathi Una adderley: Choosing the right compression Alison Hopkins: Changing the narrative...
The US FDA has announced plans to modernise its 510(k) clearance programme for approving medical devices for the US market. Data show that about 20% of current 510(k) devices are approved on trials that compare novel devices to predicate...

Ramesh Tripathi

Having worked as a vascular surgeon and venous specialist in several different countries and continents, Ramesh Tripathi has a wide-ranging experience and storied career. He tells Venous News about his current areas of research, his opinion of the most important...
Boston Scientific has announced it has reached an agreement on the terms of a recommended offer to acquire BTG, a company headquartered in the United Kingdom, which develops and commercialises products used in minimally-invasive procedures targeting cancer and vascular...
Two-year results for the SENTRY trial were presented at the Vascular Interventional Advances conference (VIVA; 5–8 November, Las Vegas, USA). The prospective, multicentre trial of the Sentry (BTG), a bioconvertible IVC filter, found that in addition to providing protection...
The 12-month results from the VERNACULAR trial have shown that the Venovo venous stent (BD Interventional) is successful when deployed in obstructive iliac and femoral lesions with a primary patency rate of 88.3%, a low reintervention rate of 7.4%,...
BTG has announced that the first EKOS Control Unit 4.0 have been shipped from BTG’s facility in Bothell (Washington, USA) to Europe, where full commercial launch will begin. New features of the EKOS CU 4.0 include an interactive colour...
There is a robust evidence base to support the use of compression therapy for healing venous leg ulceration and for preventing ulcer recurrence. The most recent version of the Cochrane Review1 on the effectiveness of compression and the relative effectiveness of different...
Theraclion has announced that Alfred Obermayer, principal investigator of the varicose vein treatment clinical trial in Austria, presented preliminary results at the Congress of the German Society of Phlebology in Bielefeld, attended by around 1,200 participants. The study aims...
At the Royal Society of Medicine (RSM) Venous Forum meeting (25–26 June, London, UK), Alison Hopkins was asked to speak about managing painful leg ulcers. She took the opportunity to focus on the need to improve the art of...
A recent Danish study, examining a nationwide cohort of 8,187 patients with venous thromboembolism (VTE) treated with one of two new oral anticoagulant therapies, reports no significant differences between the drugs in risk of all-cause mortality, recurrent VTE or...
Research presented at the European Society for Vascular Surgery’s annual meeting (ESVS; 25–28 September, Valencia, Spain) has shone a light on the potentially high cumulative radiation exposure associated with certain venous procedures. Addressing the issue, Stephen Black (Guy’s and...
In this issue: "Crystal clear" evidence that higher compression reduces ulcer recurrence New intravascular ultrasound-based scoring system may predict stent failure Managing superficial vein thrombosis Profile: Kathleen Gibson  
This article is an advertorial sponsored by plus medica The blueflow Venous Stent developed by plus medica GmbH & Co. KG received CE mark in early 2018, and has now been used in 60 patients at two centres in Europe....
A recent study which set out to investigate the usefulness of duplex ultrasound in monitoring stent changes over time, concludes that stent occlusion is related to the reduction of stent lumen over time—rather than the percent of the stenosis. Investigators...
Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency compared with non-pregnant women treated at the same centre. Katalin Lestak (St Thomas’ Hospital, London, UK) presented...
A report of an eight-year experience using diode laser for the treatment of congenital diffuse venous malformations, has shown the modality to be effective and safe with a low number of complications. The experience from the Vascular Anomalies Unit in...
A study presented at the European Society for Vascular Surgery’s annual meeting (ESVS; 25–28 September, Valencia, Spain) has concluded that mechanochemical ablation with concomitant ambulatory phlebectomy (MOCAP) results in greater early improvement in quality of life and significant reduction...

Kathleen Gibson

An accomplished vascular surgeon and prominent clinical researcher in the venous field, Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA) plays an active role in a range of venous and vascular societies, and is currently involved in developing standardisation...

Venous News 7 – September 2018

In this issue: "Crystal clear" evidence that higher compression reduces ulcer recurrence New intravascular ultrasound-based scoring system may predict stent failure Managing superficial vein thrombosis Profile: Kathleen Gibson  
Anna Louise Pouncey revealed at the European Venous Forum annual meeting (EVF; 28–30 June, Athens, Greece) the findings of the GSTT venous team (Guy’s and St Thomas’ NHS Foundation Trust & Kings College London, London, UK) that early use...
Superficial vein thrombosis is not a rare disease, with an incidence of 0.64 in 1,000 annually.1 The POST, OPTIMEV and STEPH studies have shown that superficial vein thrombosis may be associated with a considerable risk of concomitant deep vein...
The utility of combining patient- and physician-reported scores to stratify disease severity and treatment rationale in patients with varicose veins has been highlighted in a recent study by Lowell Kabnick, Thomas Wakefield, Mikel Sadek, Jose Almeida and Glenn Jacobowitz,...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk of venous thromboembolic events. Novate has developed Sentry, the first bioconvertible inferior vena cava filter, which...
Mermaid Medical Group, a privately-owned international provider of minimally invasive medical devices, acknowledged a product line addition to its vascular business. As part of its strategic focus for expanding their vascular product portfolio, Mermaid Medical Group announced the acquisition...
Alex C Spyropoulos, from Feinstein Institute for Medical Research (New York, USA), has presented an anticoagulant treatment strategy to reduce non-fatal blood clots and pulmonary embolism in acutely-ill hospitalised patients, according to clinical findings published in The New England...
One of the first randomised controlled trials comparing two therapeutic regimes—surgery and foam sclerotherapy—in patients with anterior accessory saphenous vein (AASV) varicosis, has found that surgery can outperform foam sclerotherapy in terms of duplex sonographic recurrence after one year....
To accompany the growing importance of intravascular ultrasound (IVUS) as an adjuvant diagnostic tool when treating deep venous disease, a study sought to create an IVUS-based scoring system able to predict venous stent failure in the treatment of May-Thurner...
Hancock Jaffe Laboratories, a company specialising in bioprosthetic medical devices for treating cardiac and vascular diseases, has received approval for the first-in-man testing of its VenoValve bioprosthetic venous valve device from the Medical Research Committee at Fundación Santa Fe...
According to Fedor Lurie (Jobst Vascular Institute, Toledo, USA), who presented at the European Venous Forum Annual Meeting (EVF; 28–30 June, Athens, Greece), patients with a high probability of iliofemoral deep vein thrombosis (DVT) are not diagnosed early enough...
A first prototype of a novel endovenous therapy technology (SnakeBack, LSO Medical) integrated with a laser ablation platform was revealed earlier this year at the Charing Cross Symposium (CX; 24-27 April, London, UK) by Philippe Rochon, president of LSO...
Boston Scientific has signed an agreement to acquire Veniti, a privately-held company in Fremont, USA which developed and commercialised the Vici venous stent system for treating venous obstructive disease. Boston Scientific has been an investor in Veniti since 2016 and...
NexGen Medical Systems, Inc., a US medical device company, has announced the successful completion of the first human use of their XCOIL large vessel (18mm) thrombectomy system for the treatment of deep vein thrombosis (DVT). The new device, an expansion...
A new analysis has identified patient populations with cancer-associated venous thromboembolism (VTE) who could benefit from treatment with oral anticoagulant edoxaban, taken once daily. Daiichi Sankyo has announced the publication of a new analysis, focusing on the clinical presentation, course...
A Cambridge study has found that most inpatients with leg ulcers were not referred to a vascular surgery team, indicating a need to improve pathways of care for inpatients with leg ulcerations. The results of the study conducted at Addenbrooke’s...
Venclose has announced the closing of an oversubscribed Series B round of financing from new and existing investors. Proceeds from the financing will be used to support new product development, expansion of manufacturing capabilities and general corporate purposes. The company...
EchoNous Vein (EchoNous), an ultrasound-based tool designed specifically for nurses to improve peripheral IV catheter placements, has received US Food and Drug Administration (FDA) approval. A company release explains that EchoNous Vein provides immediate, clear images at depths from 1–5cm...

Alun Davies

Alun Davies is a Welsh-born leading expert in the venous field, one of the Editors-in-Chief of Venous News, and currently in the spotlight as chief investigator of the EVRA ulcer trial. In this profile, Davies talks about the implications...
Highlights: Landmark EVRA trial provides first Level 1 evidence for early venous ablation Ultrasound-guided foam sclerotherapy of small saphenous vein as effective as endovenous laser ablation for venous clinical severity score and quality of life at one year Rick...
Highlights: Landmark EVRA trial provides first Level 1 evidence for early venous ablation Ultrasound-guided foam sclerotherapy of small saphenous vein as effective as endovenous laser ablation for venous clinical severity score and quality of life at one year Rick...
An analysis of post-thrombotic disease patients who received a nitinol stent has found that ultrasound surveillance should occur at frequent intervals up to two weeks post-procedure to predict risk of re-intervention. The results of the study were presented at the...
A new randomised controlled trial evaluated the preventative effect of compression stockings during pregnancy on the incidence of varicose veins as well as venous thromboembolism, with results suggesting that women with no venous disease using compression stocking during pregnancy...
BTG has announced a strategic partnership with the PERT Consortium to advance the science of pulmonary embolism treatment and promote the implementation of PERT programmes across the USA. The partnership was announced at the annual PERT Consortium Meeting (22–23...
The annual census of UK consultants and higher speciality trainees—Focus on Physicians 2017–18—indicates that more than half of all consultants and two thirds of trainees reported frequent gaps in trainees’ rotas, with one in five respondents saying these are...
The one-year results of the ACCESS PTS trial have shown that EKOS therapy (BTG) statistically improves post-thrombotic syndrome scores and sequelae as well as quality of life outcomes. Presenting the data at the Charing Cross Symposium (24–27 April, London,...
Cees Wittens writes for Venous News about the current state of deep venous obstruction interventions, what we might expect in the near future, and what is needed in terms of new technology, strategy and policy in 2018. In general, everybody...
Treatment of patients with pelvic venous disorders is a “controversial topic,” Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA) said at the Charing Cross Symposium (CX; 24–27 April, London, UK), as there is “no consensus on the best mode...
New data from the MERCURY PE study have shown that patients with low-risk pulmonary embolism who were treated with the direct oral anticoagulant rivaroxaban, trade name Xarelto (Janssen Pharmaceutical), and discharged from the emergency department had significantly reduced time...
St Paul's Hospital in Vancouver, Canada has successfully completed two implantations of the VenusP-Valve (Venous Medtech), a self-expanding pulmonary valve. This is the first appearance of Venus Medtech's transcatheter valve products in North America. Although surgical treatment of congenital heart disease has evolved...
Major global wound care company Acelity is acquiring Crawford Healthcare, a growing UK-based advanced wound care and dermatology company, along with all of its assets. The companies announced the acquisition today, but did not disclose the terms of the...
Countries in the European Union have long been the first to receive new innovations in medical technology, as the EU’s Medical Device Directive (MDD) provided quicker routes to implementation of new devices than its equivalent in the USA, the...
Data presented at the Charing Cross Symposium (24–27 April, London, UK) indicate that a rounder post-stent lumen shape has a positive correlation to 12-month patient improvement, placing emphasis on the change of lumen shape from pre- to post-stent and...
Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has announced that it completed its Series A financing, totaling US$10.5 million. Major participants in the Series A financing included New Enterprise Associates and Quaker...
Inari Medical have announced the presentation of results from its FlowTriever Pulmonary Embolectomy (FLARE) clinical study that evaluated the safety and effectiveness of the FlowTriever Retrieval/Aspiration System for the treatment of pulmonary embolism. The results were presented by Thomas Tu, an...
According to a debate at the Charing Cross Symposium (CX; 24–27 April, London, UK), the vast majority of CX delegates disagree with the view that the ATTRACT trial has provided the definitive answer on the use of pharmacomechanical catheter-directed...
For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic of discussion. In this article, Rick de Graaf reviews the recent history of venous stenting...
Preliminary data from the Fovelass trial, presented at the Charing Cross Symposium (24–27 April, London, UK) by Claudine Hamel-Desnos (Caen, France) show that at one-year follow-up, the rate of occlusion of the small saphenous vein is lower after ultrasound...
The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium (CX; 24-27 April, London, UK). The presentation was accompanied by simultaneous publication in the New England Journal of Medicine...
Cardiva Medical, a vascular closure device company, today announced it has received approval from the US Food and Drug Administration (FDA) for an expanded indication of the VASCADE Vascular Closure System. Already approved for use in arterial closure, the...
The Royal Society of Medicine Venous Forum council has created a document that is intended to aid physicians when treating patients with leg ulcers. The document, “Management of Patients with Leg Ulcers”, indicates that urgent action is needed to ensure that...
Intravascular ultrasound (IVUS) imaging technology provides the current gold standard technique for detection and characterisation of venous disease, Erin Murphy writes. In this article, Murphy discusses the limitations of venography and outlines the use of IVUS for optimised outcomes...
Venture-backed medical device company Inari Medical has announced the close of a Series C financing totaling US$27 million. The company plans to use the capital to commercialise its catheter devices for the treatment of venous thromboembolism. The financing was led by new...
Medical device company Plus medica has announced that 10 patients have been treated with the company’s blueflow Venous Stent. The first cases were performed by Michael Lichtenberg, Klinikum Arnsberg, Arnsberg, Germany, and Nils Kucher, University Hospital Zurich, Zurich, Switzerland. The...
The handheld medical imaging system HyperView (HyperMed Imaging) has received CE mark, allowing for distribution in Europe. The system is designed to detect perfusion of superficial tissue in support of wound care. The HyperView System is a fast, handheld, battery...
Representation is essential in the constantly changing medical landscape that healthcare professionals are facing. The American College of Phlebology (ACP) has begun several new initiatives recently to improve the representation of venous and lymphatic health care providers within the...
The deep venous world is wrestling with the question: To stent or not to stent. While the availability of new specialised venous stents is boosting popularity for the technique, there are some reservations about the appropriateness and risks of...
Following the announcement of receiving the CE mark in early 2018, ab medica has now reported the first-in man usage of its blueflow Venous Stent. The company signed an exclusive distribution agreement for the blueflow Venous Stent with plus medica...
The common diagnosis of post-thrombotic syndrome (PTS) includes a history of deep venous thrombosis and a Villalta Scale score of four or above. However, a recent study conducted by JOBST Vascular Institute of ProMedica, examining whether misclassification bias might occur...
The International Union of Phlebology World Congress (UIP) will head to Turkey in 2021 after Istanbul successfully won the bid to be the host city of the next meeting. The battle for the host city of UIP 2021 was hotly...
Highlights: CX presents comprehensive Venous Controversies programme UIP audience votes against stenting as standard for deep vein obstruction Setting the record straight: Clarifying the misconceptions of the ATTRACT trial Erin Murphy: Use of IVUS to optimise outcomes in venous...
Highlights: CX presents comprehensive Venous Controversies programme UIP audience votes against stenting as standard for deep vein obstruction Setting the record straight: Clarifying the misconceptions of the ATTRACT trial Erin Murphy: Use of IVUS to optimise outcomes in venous...
Rick de Graaf speaks to Venous News about complications from venous stenting, including causes and best treatment approaches for reinterventions after stenting.
A special session during the pre-conference Day of Innovation and Science at the American Venous Forum annual meeting (AVF; 20–23 February, Tucson, USA) presented the rare occasion for attendees to listen to and interact directly with the principal investigator...
A recent study on iliac vein stenting following catheter-directed thrombolysis for deep vein thrombosis (DVT) has shown that technical and clinical success  require high thrombus clearance rates, and stenting below the inguinal ligament does not have an adverse outcome...
After five years, the board of the European College of Phlebology is changing, announced Eberhard Rabe (University of Bonn, Bonn, Germany) at the European Vascular Course (EVC; 4–6 March, Maastricht, The Netherlands). The election is to be held among...
The blueflow Venous Stent (plus medica) received the CE mark in January 2018. The news was announced via a company release in March. The blueflow Venous Stent, developed and manufactured in Germany is a two nitinol wire braided stent used to...
UK-based Inotec AMD Limited has announced the appointment of Craig Kennedy as its new chief executive officer on 3 March 2018. Inotec AMD is a maker of mobile medical devices designed to heal chronic, hypoxic wounds that afflict millions of...
At the American Venous Forum (AVF; 20–23 February, Tucson, USA), a session on venous leg ulcers turned to possible future treatment strategies as Kathleen Gibson (Lake Washington Vascular Surgeons, Bellevue, USA) spoke about off-label uses of cyanoacrylate and polidocanol...
Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent. Presenting the data at the Leipzig Interventional Course (LINC; 30 January­–2 February, Leipzig, Germany), the registry’s principal investigator Michael...

Armando Mansilha

Armando Mansilha is professor of Angiology and Vascular Surgery, Faculty of Medicine at the University of Porto, Porto, Portugal. In this interview with Venous News, he speaks about his early work and mentors, the biggest developments in venous medicine...
The Food and Drug Administration (FDA) has today issued the final rule on “human subject protection; acceptance of data from clinical investigations for medical devices”. The rule updates the FDA’s standards for accepting clinical data from clinical investigations conducted...
“Endovascular reconstruction of the chronically obstructed iliocaval venous tract with stents is technically feasible, minimally invasive and has an acceptable safety rate, said James Budge, Department of Vascular Surgery, Guy’s and St Thomas’, London, UK. “Patients who underwent this procedure...
Following the publication of the ATTRACT trial in the New England Journal of Medicine (NEJM) in December 2017, Venous News spoke to experts in the field to analyse the data and formulate future research questions. One of the interesting...
Highlights: Published ATTRACT data call into question validity of the Villalta scale Brave Dreams trial finds venoplasty “safe, but largely ineffective” for MS patients Johann C Ragg: Percutaneous valvuloplasty Nicholas Osborne: VQI Varicose Vein Registry Profile: Armando Mansilha https://venousnews.com/wp-content/uploads/sites/19/2018/02/Venous-News-4-low-res-US.pdf

Venous News 4 – January 2018

Highlights: Published ATTRACT data call into question validity of the Villalta scale Brave Dreams trial finds venoplasty “safe, but largely ineffective” for MS patients Johann C Ragg: Percutaneous valvuloplasty Nicholas Osborne: VQI Varicose Vein Registry Profile: Armando Mansilha https://venousnews.com/wp-content/uploads/sites/19/2018/02/Venous-News-4-low-res-EU.pdf
LimFlow has announced completion of enrolment of the original 10-patient cohort in the US feasibility study of the LimFlow percutaneous deep vein arterialisation system. The company also announced that the US FDA has accepted the company’s proposal to expand...
Medtronic has announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and effectiveness of the Abre stent in patients with iliofemoral venous outflow...
Members of the venous community have had a longstanding commitment to collecting and analysing the outcomes of venous procedures. The Vascular Quality Initiative (VQI) Varicose Vein Registry (VVR) grew out of a previous registry established by the American Venous...
Venous specialists from around the globe will meet in Melbourne for the much anticipated 2018 World Congress of Phlebology (UIP; 4–8 February, Melbourne, Australia) hosted by the Australasian College of Phlebology.  The president of UIP (International Union of Phlebology), Nick...
Compression therapy for venous ulcers requires accurate monitoring to ensure successful delivery and the desired compression dose. However, according to a study presented at the American College of Phlebology annual meeting (ACP; 2–5 November, Austin, USA), the level of...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced findings from the US Food and Drug Administration's (FDA) mini-sentinel assessment, confirming the positive safety and efficacy profile of Xarelto (rivaroxaban) established in the phase III ROCKET AF clinical trials,...
Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in cancer patients. The Hokusai-VTE CANCER study is a phase 3b, prospective, randomised, open-label, blind end-point study...
The European Board of Phlebology has announced that the European Union of Medical Specialists (UEMS) have adopted the European training requirements presented by Jean-Jérôme Guex, president of the newly created Board. The development is the result of a European...
Global specialist healthcare company BTG has highlighted the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of pulmonary embolism utilising...
Venous stenting has evolved over the last 15 years, quickly becoming an established procedure, with Class II recommendations from the American Heart Association and American College of Phlebology. Speaking at the Vascular Society of Great Britain and Ireland’s Annual...
Leg ulceration is the poor relation of vascular disease, yet, as Sophie Renton writes, it is a very common problem. It is estimated that 1/1,000 people in the UK will have a leg ulcer at some stage in their lives. Leg ulcers become...
More than 25% of the adult population is affected by varicose veins, with more than a 15% prevalence of chronic venous insufficiency (C3–C6), which induces a considerable burden on the health of these patients. The Bonn Vein Study found that 21% of the...
At the THE VEINS at VIVA meeting (10–11 September, Las Vegas, USA), Esther Kim (Vanderbilt University Medical Center, Nashville, USA) gave a presentation on venous thrombosis in unusual locations, noting that such thromboses tend to occur in younger patients and those with malignancy,...
At THE VEINS at VIVA meeting (10–11 September 2017, Las Vegas, USA), James Froehlich, University of Michigan, Ann Arbor, USA, reviewed guidelines on the management of superficial venous thrombosis (SVT) and emphasised the importance of performing duplex ultrasound in the examination, assessing clot location...
Cardiff Metropolitan University has announced it has secured a grant to “support an interdisciplinary collaboration of an innovative sterilising device for venous access ports (VAPs).” Existing VAPs tend to encourage the build-up of bacteria and fungus in the port, leading...
BTG has announced its finalised category I CPT codes, received from the US Centers for Medicare and Medicaid Services. The codes will be be effective from 1 January, 2018. The fee schedule details payments for conducting Varithena treatments in the...
Cardiff Metropolitan University has successfully secured funding to support an interdisciplinary collaboration arising from the Welsh Crucible programme that looks at the design and development of an innovative sterilising device for venous access ports (VAPs). The interdisciplinary research is a...
The US Centers for Medicare and Medicaid Services (CMS) has posted the 2018 Medicare Physician Fee Schedule (CMS-1678-F) and Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems (CMS-1678-FC). As part of the final rulings, healthcare providers will...

Nick Morrison

Nick Morrison chose venous medicine as he wanted a challenging career. Although he initially worried that he would become bored working in the venous field, his long and distinguished career since then is proof of the complexity and depth of...
Continuing work to develop an improved percutaneous valvuloplasty procedure “is promising”, said Johann Chris Ragg (Angioclinic Vein Centers, Berlin, Munich, Germany, and Zurich, Switzerland), as he updated delegates on the technique at the annual American College of Phlebology meeting...
Inferior vena cava (IVC) filters have been a highly controversial topic in the field of venous medicine due to the high rates of complications associated with their use, which eventually prompted a 2010 US Food and Drug Administration (FDA) advisory and declining...
Highlights: -MOCA and EVLA show similar overall pain scores and improvements in quality of life and clinical outcomes -First European advice on deep vein thrombosis published in European Heart Journal -Armando Mansilha: Chronic venous disease -Sophie Renton: Venous ulceration guidelines -Profile:...

Venous News 3 – November 2017

Highlights: -MOCA and EVLA show similar overall pain scores and improvements in quality of life and clinical outcomes -First European advice on deep vein thrombosis published in European Heart Journal -Armando Mansilha: Chronic venous disease -Sophie Renton: Venous ulceration guidelines -Profile:...
While comparative study data for venous stents are still lacking, results of a number of ongoing and planned venous stent trials will increase the options currently available to physicians and provide useful comparative data, explained Stephen Black (London, UK),...
Endovascular treatment of iliocaval and infrainguinal post-thrombotic venous obstruction results do not appear to be adversely affected by extension of the iliac vein stents into the femoral venous system, according to a US report in the Journal of Vascular...
Janssen Pharmaceuticals has announced that the FDA has approved the 10mg once-daily dose of rivaroxaban (Xarelto) for reducing the continued risk for recurrent venous thromboembolism (VTE) after completing at least six months of initial anticoagulation therapy. The approval follows a...
Inari Medical has announced that it has completed enrolment of its investigational device exemption (IDE) study. The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study is designed to evaluate the safety and effectiveness of the FlowTriever Retrieval/Aspiration System for the...
Deep venous stenting has become increasingly used to treat patients with pathological obstruction of venous return in the femoro-iliocaval venous segment following the development of new dedicated venous stents. Patients treated range from those with an isolated non-thrombotic iliac vein lesion, to those...
Marianne De Maeseneer

Marianne De Maeseneer

Marianne De Maeseneer already wanted to become a doctor by the age of 12, with her imagination captured by the idea of working in developing countries. A “series of coincidences” led her towards vascular and venous medicine, in which...
The first comprehensive European advice on deep vein thrombosis was recently published in the European Heart Journal. The recommendations were produced by the European Society of Cardiology (ESC) Working Group on Aorta and Peripheral Vascular Diseases and Working Group...
The world’s largest randomised trial comparing three central venous access devices—peripherally inserted central catheters (PICCs), Hickman-type devices and chest wall ports—should provide definitive results in terms of their relative efficacy and cost-effectiveness, Jon Moss, Glasgow, UK, told CIRSE delegates. The...
Gerard Goh, Radiology, The Alfred Hospital, Melbourne, Australia, reported results from a comparative study of inferior vena cava (IVC) filters at CIRSE 2017 that examined the effectiveness, safety and complication rates of the Celect, Celect Platinum and ALN vena...
Data from the LAMA (Laser ablation versus mechanochemical ablation) trial indicate that mechanochemical ablation (MOCA) is significantly less painful than endovenous laser ablation (EVLA) during treatment of superficial venous incompetence, though there is no difference in pain between the...
There are two things you need to know about me. Firstly, I am a health psychologist, with a specialist interest in behaviour change, implementation, and impact. Secondly, through a series of deep vein thromboses (DVTs) beginning with a post-partum iliofemoral clot in 2008...
Emerging evidence suggests that the lymphatics play an important role in the early pathogenesis and progression of peripheral arterial and venous diseases, suggest John Rasmussen and Eva Sevick-Muraca, writing for Venous News.  Functioning peri-adventitial lymphatics are essential for reverse cholesterol transport by macrophages to...
Although the venous stent is still a young technology, it is already offering new and exciting opportunities to patients with deep venous occlusive disease. Venous News spoke to Manjit Gohel (Cambridge, UK) about how his experience in with deep venous stenting,...
ElastiMed has raised US$1 million from a strategic investor, existing investors—The Trendlines Group and Pix Vine Capital—new private investors, and the Israeli Innovation Authority. This represents the company's second round of funding, bringing total raises to US$2 million to...
Inferior vena cava (IVC) filters have long been a controversial topic, and some physicians have even called for a total moratorium on their implantation. Venous News spoke to John Kaufman (Portland, USA) at the 2017 Vascular Interventional Advances 2017...
A study has shown modified human factor X to be a safe and effective reversal agent for prevention and treatment of bleeding in patients taking factor Xa oral anticoagulants. This new therapeutic factor X was inspired by a snake...
Twelve-month results from the SENTRY trial evaluating the Sentry bioconvertible inferior vena cava (IVC) filter (Novate) have shown a 0% rate of symptomatic pulmonary embolism, no instances of device failure and a 96% rate of bioconversion. Presenting that data...
Spectranetics has recalled the Bridge occlusion catheter “due to the possibility of a blocked guidewire lumen in some device units”. Using affected catheters could lead to the incorrect positioning of the device and subsequent uncontrolled haemorrhage. Spectranetics’ Bridge occlusion balloon...
Highlights: -Five-year data find foam sclerotherapy to be less effective than thermoablation or stripping for varicose veins -Questions remain over venous leg symptoms despite SYM vein consensus -Manjit Gohel: Stent flexibility -Eva Sevick-Muraca: Lymphoedema -Profile: Marianne De Maeseneer https://venousnews.com/wp-content/uploads/sites/19/2017/09/Venous-News-2-low-res_USA.pdf

Venous News 2 – September 2017

Highlights: -Five-year data find foam sclerotherapy to be less effective than thermoablation or stripping for varicose veins -Questions remain over venous leg symptoms despite SYM vein consensus -Manjit Gohel: Stent flexibility -Eva Sevick-Muraca: Lymphoedema -Profile: Marianne De Maeseneer https://venousnews.com/wp-content/uploads/sites/19/2017/09/Venous-News-2-low-res.pdf  
ManaMed has introduced PlasmaFlow, the first US Food and Drug Administrator-approved portable and tubeless deep vein thrombosis (DVT) prevention device throughout the USA. "We at ManaMed are thrilled that our innovative PlasmaFlow DVT prevention device is available to help mitigate...
Medtronic is expanding its embolisation product portfolio with the launch of the Concerto 3D detachable coil system. The system was launched at the Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE; 16–20 September, Copenhagen, Denmark). The Concerto 3D...
InGeneron has announced the publication of results from an investigator initiated case series in chronic leg wounds in the Journal of the European Academy of Dermatology and Venereology. In the case series, InGeneron’s proprietary adipose-derived regenerative cell (ADRC) technology was...
Boston Scientific will distribute Veniti’s Vici venous stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries involved have not been disclosed. Launched in 2014, the Vici venous stent has gained wide market...
Straub Medical has announced that the first patient has been enrolled in the P-MAX study at the Karolinen-Hospital Arnsberg, Germany.  The post-market clinical follow-up study to assess the safety and effectiveness of the AspirexS venous catheter in the treatment of deep vein thrombosis will enrol over 80 patients by...
Results from a Czech study indicate that 1470nm laser treatment of saphenous vein reflux with both radial single-ring and 2ring fibres results in clinical improvement of symptoms and comparable occlusion rates. That said, in the early postoperative period, 2ring laser...
At the 2017 European Venous Forum (29 June–1 July, Porto, Portugal), a presentation given by Eberhard Rabe (Bonn, Germany) questioned whether the SYM Vein Consensus clarified all aspects of venous symptoms. Speaking with Venous News, Rabe explains which questions still remain regarding venous leg symptoms...

VIDIO trial results published

The VIDIO study, led by Paul Gagne, Southern CT Vascular Center, Darien, USA, showed that intravenous ultrasound (IVUS) is more sensitive for assessing treatable iliofemoral vein stenosis compared with multiplanar venography and frequently leads to revised treatment plans and the potential for improved clinical outcome.  The...
The American College of Phlebology (ACP) board of directors has selected Dean Bender as the new executive director for the ACP and ACP Foundation.  Bender has more than 30 years in global business management and considerable experience in venous and lymphatic medicine. He has served as vice president of business...
Teleflex has announced a new three-year product category contract with Vizient for non-tunnelled central venous catheters. Vizient is the largest member-driven health care performance improvement company in the USA. The new agreement for non-tunnelled central venous catheters, which became effective...
Medtronic has completed the previously announced sale of a number of its businesses to Cardinal Health, including its Deep Vein Thrombosis (compression) division. The transaction was worth US$6.1 billion. The company has also sold its Patient Care and Nutritional Insufficiency...
Venous News caught up with Lars Rasmussen (Danish Vein Centres, Denmark) at the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal) to hear about his five-year follow-up comparing endovenous radiofrequency ablation, laser ablation, foam sclerotherapy and surgical stripping...
Writing for Venous News, Paul Gagne (Darien, USA) notes that during the past decade, evaluation and treatment of iliac or common femoral vein obstructive disease have become more familiar and common. Based on the landmark work pioneered by Peter...
The first results from the GARFIELD-VTE (Global anticoagulant registry in the field—venous thromboembolism) were presented at the International Society on Thrombosis and Haemostasis Congress 2017 (8–13 July, Berlin, Germany) providing a contemporary picture of VTE management worldwide. GARFIELD-VTE is a...
At the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal), Mattia Mirandola (Peschiera del Garda, Italy) presented his four-year experience of using ClariVein (Vascular Insights) for mechanochemical ablation of the saphenous vein. He shared his results with Venous...
Endovenous adhesive closure systems are a useful adjunct to thermal ablation treatment for varicose veins, but it is vital that the possible side-effects of such treatments are discussed openly with patients pre-procedurally, according to a presentation at the European...
The UK’s Information Commissioner’s Office (ICO) has found that the Royal Free National Health Service (NHS) Foundation Trust (London, UK) did not adhere to the UK’s Data Protection Act when it provided patient details to Google DeepMind. The Trust, a...
A presentation at the American Venous Forum (AVF; 14–17 February, New Orleans, USA) has attempted to shed light on what could be an underdiagnosed cause of pelvic pain caused by pelvic venous insufficiency—iliac vein compression. Ratnam K N Santoshi (Center...
A study presented at the American Venous Forum (AVF; 14–17 February, New Orleans, USA) suggests that secondary interventions for primary iliac vein stenting are “associated with good outcomes,” with a rate of 10.2% reported. Aiya Aboubakr (Mount Sinai Hospital, New...
Bio2 Medical has announced the results of the Angel Catheter pivotal study published in the Journal of Vascular and Interventional Radiology. The Angel Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary...
The US Food and Drug Administration (FDA) has accepted, for priority review, a supplemental new drug application (sNDA) for Janssen’s Xarelto (rivaroxaban), to include a 10mg once-daily dose for reducing the risk of venous thromboembolism (VTE) after at least...

Keith Poskitt

Coming from a non-medical background, Keith Poskitt is unable to pinpoint exactly how his interest in the field developed. At school, science and sports—rugby and cricket in particular—vied for his attention. Following a serious ankle injury at the age of...
The US Food and Drug Administration (FDA) has approved betrixaban (Bevyxxa, Portola), the first and only anticoagulant for hospital and extended duration prophylaxis (35 to 42 days) of venous thromboembolism (VTE) in adult patients hospitalised for an acute medical...
Researchers at North Carolina State University (Raleigh, USA) and the University of North Carolina at Chapel Hill (Chapel Hill, USA) have developed a new surgical tool that uses low-frequency intravascular ultrasound to break down blood clots that cause deep...
Public Health England (PHE) and the Royal Society for Public Health (RSPH) have published “Everyday Interactions”, a report which aims to support healthcare professionals to record and measure their public health impact.  The report and toolkit were developed in close...
The results of the ACCESS PTS trial have been presented at the Society for Vascular Medicine 28th Annual Scientific Sessions (14–17 June, New Orleans, USA). The study found chronic deep vein thrombosis (DVT) patients with post-thrombotic syndrome (PTS) can...
New evidence suggests that minimally invasive methods to ablate superficial venous reflux in patients with end-stage venous insufficiency are as effective as traditional open venous stripping. Chronic venous insufficiency affects approximately 2.5 million Americans, with up to 20% developing venous...
In this supplement: Life post-ATTRACT: The new challenge of DVT treatment --The future of DVT intervention in Europe: what needs to happen next --"With careful patient selection and a patent popliteal vein, DVT treatment can be completed in less...
Kathleen Gibson, Bellevue, USA, presented the three-year results of the VeClose clinical trial at the recent Charing Cross Symposium. Gibson spoke to Venous News about the study and about how she interprets the three-year data.
Results from the OPTALYSE PE trial have been presented at the American Thoracic Society International Conference in Washington, DC, USA. The results show that pulmonary embolism (PE) can be treated effectively with EKOS (BTG) over a shorter period and...
Highlights: -ATTRACT results are “a springboard” for future pharmacomechanical thrombolysis research -Paul Gagne: Stenosis threshold -Peter Gloviczki: A look into the future -Profile: Keith Poskitt https://venousnews.com/wp-content/uploads/sites/19/2017/05/Venous-News-1-US_low-res.pdf
Highlights: -ATTRACT results are “a springboard” for future pharmacomechanical thrombolysis research -Paul Gagne: Stenosis threshold -Peter Gloviczki: A look into the future -Profile: Keith Poskitt https://venousnews.com/wp-content/uploads/sites/19/2017/05/Venous-News-1-EU_low-res-1.pdf
At the American Venous Forum meeting (14–17 February, New Orleans, USA), Johann Christof Ragg (Berlin/Zurich, Germany/Switzerland), presented on the concept of obtaining ultrasound proof of pre-reflux stages of venous insufficiency. Ragg spoke to Venous News about what light his...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of post-thrombotic syndrome in patients who received this treatment strategy when compared with its occurrence in...
Three-year outcomes from the VeClose US pivotal clinical trial and one-year data from the WAVES study have been presented at the 2017 CX Symposium in London, UK. Both results were presented by Kathleen Gibson (Bellevue, USA). The new data...
Isobar Compression has been awarded a research contract from the Small Business Research Initiative (SBRI) for Healthcare, to assist in a feasibly study in primary care for the treatment of venous leg ulcers. The research contract was awarded by SBRI...
Bluegrass Vascular Technologies has enrolled over one third of its patients in the company's post-market SAVE (Surfacer System to Facilitate Access in Venous Occlusions) clinical study. The SAVE study is an international, prospective, multicentre clinical follow-up study designed to...
Research published in Phlebology has indicated that the 2013 UK varicose veins clinical guidelines have led to “a considerable increase” in leg ulcer patient referrals, although many patients are still not being referred early enough, the authors of the paper...
Inari Medical, a venture capital backed medical device company focused on the interventional treatment of venous thrombus, has announced the treatment of the first patient with its ClotTriever thrombectomy system.  The system received 510(k) marketing clearance from the US Food and...
Further evidence has been found by researchers at the UK’s University of Leicester and University of Bristol to suggest statins could "significantly reduce" the occurrence of blood clotting in certain parts of the body. The research team analysed several studies...
Compression therapy is the mainstay of treatment for the symptoms of chronic venous insufficiency (CVI). CVI is treated with compression stockings or multilayer bandaging. However, as most compression stockings are supplied in standard sizes, they frequently failed to deliver...
The use of dedicated nitinol venous stents across the inguinal ligament shows “good outcomes” in terms of patency but reinterventions may be required, according to Prakash Saha, Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London,...
Most existing surgical options for symptomatic deep venous insufficiency (DVI) with venous stasis ulcers either fail or provide limited success. Many surgeons consider operating on large veins such as the common femoral vein to be foolhardy—something new is required,...
A Canadian-led international research team has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of life-threatening blood clots in the legs and lungs, according to a study published in the...
In a new study presented at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that the utilisation rates of these potentially life-saving medications are low, particularly in...
Unfors RaySafe has introduced the RaySafe i3, to its suite of real-time dosimetry products, at the European Society of Radiology in Vienna.   The RaySafe Real-Time Dosimetry solution, introduced in 2012, helps physicians and clinical staff visualise X-ray exposure in real...
The use of computerised clinical decision support systems among surgical patients are associated with a significant increase in the proportion of patients with adequately ordered treatment to prevent blood clots, and a significant decrease in the risk of developing...
CorVascular has entered into a distribution agreement with Novarix. The IV-eye, developed and manufactured in the UK by Novarix, is a near infrared (NIR) vein imaging device designed to aid healthcare professionals in finding suitable peripheral veins for both cannulation...
Nobilis Health has closed its previously announced acquisition of Hamilton Vein Center. “Hamilton Vein Center not only increases our in-network patient volume mix to over 60%, but its six facilities enhance our network of physicians, allowing Nobilis to generate additional...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of post-thrombotic syndrome in patients who received this treatment strategy when compared to its occurence in...
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up with Raghu Kolluri (OhioHealth Vascular Institute, Columbus, USA) who explained his experience with the system...
Primary chronic venous disease is poorly documented in paediatric patients, excluding those diagnosed with Klippel-Trenaunay syndrome (KTS) and post-thrombotic syndrome, writes Dawn Coleman. The Bochum Study previously studied 136 children (aged 10–12 years) longitudinally out to 31 years and...
Having received CE mark approval in July and Health Canada approval in August of last year, FlowAid Medical Technologies has now received US Food and Drug Administration (FDA) clearance for its FA100 SCCD (Sequential Continuous Contraction Device) for the following indications: increase of...
In this clinical study the one-year results of the endovenous laser therapy (ELT) application of 1,940nm laser (Vela XL, Boston Scientific) with respect to feasibility, efficacy and safety are reported. Anna Esipova and colleagues investigated the performance of longer...
The question is often asked: is intravascular ultrasound (IVUS) necessary in a deep venous practice? Stephen Black writes that it was certainly a question that he had asked when initially building his practice. The answer predominantly seemed to be that...
In this interview, Vascular News speaks to Prakash Saha, King’s College Hospital, London, UK, about the growth of deep venous treatment and how the field can best address the ever-growing list of challenges. What are the challenges you face...
Following Health Canada regulatory approval, BTG is to launch its polidocanol injectable foam (Varithena), a drug/device combination product used to treat varicose veins, in Canada. The product is intended for use in adults with clinically significant venous reflux as...
Two-year outcomes of the VeClose pivotal trial have been reported, showing a 94.3% closure rate and “continued non-inferiority results to radiofrequency ablation” when using the VenaSeal cyanoacrylate embolic adhesive closure system (Medtronic). The data were presented by Raghu Kolluri,...
A Dutch study of greater saphenous vein insufficiency patients has found that mechanochemical ablation (MOCA; ClariVein, Vascular Insights) is an effective and safe treatment with low postoperative pain and fast recovery. Speaking at the 2016 VEITHsymposium (15–19 November, New...
Fresh data from a Turkish CAPE (cyanoacrylate adhesive perforator embolisation) trial indicate that the method is “as effective as endovenous thermoablative techniques, without the risks of potential inadvertent thermal lesions” for treating incompetent perforating veins. The presentation was given...
Highlights: -Animal experiments raise possibility of wireless vascular flow monitoring -Global variations in abdominal aortic aneurysm care revealed -Jerry Fortuna: Battlefield trauma -Stephen Black: IVUS -Profile: R Clement Darling III http://venousnews.com/wp-content/uploads/sites/19/2017/01/73-VN-US-v2.pdf
Highlights: -Animal experiments raise possibility of wireless vascular flow monitoring -Global variations in abdominal aortic aneurysm care revealed -Jerry Fortuna: Battlefield trauma -Stephen Black: IVUS -Profile: R Clement Darling III http://venousnews.com/wp-content/uploads/sites/19/2017/01/73-VN-v2.pdf
Robert Califf is to step down as US Food and Drug Administration (FDA) commissioner upon the inauguration of Donald Trump as US President on 20 January 2017. Democrat Califf, who was appointed to the post in September 2016 by...
The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an ultrasonic device that uses acoustic pulses to quickly and safely dissolve blood clots and restore...
Teleflex’ Arrow Vascular positioning system (VPS) Rhythm device with optional TipTracker technology has been issued 510(k) clearance from the US Food and Drug Administration (FDA) to commercialise the device in the USA. According to a company release, the Arrow VPS...
Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides Abbott with expanded opportunities for future growth and is an important part of the company's...
Gerard O’Sullivan, Department of Radiology, University Hospital Galway, Ireland, presented the results of the VIVO-EU prospective study of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic iliofemoral outflow obstruction at the Cardiovascular and Interventional Radiological...

US FDA bans powdered gloves

The US Food and Drug Administration (FDA) has issued a final rule to ban powdered surgical gloves, patient examination gloves and the absorbable powder used to lubricate surgical gloves. Citing associations with serious adverse events—including allergic reactions, lung and airway...
The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication Taskforce. This programme aims to accelerate US patient access to new technologies by gathering evidence...
The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical data on the use of once-daily edoxaban (Lixiana) with regard to diagnostic and interventional procedures...
LimFlow has received CE mark for its fully percutaneous LimFlow system designed for venous arterialisation of the lower limbs in end-stage patients at risk of limb amputation for critical limb ischaemia. The LimFlow system is a percutaneous therapy for patients...
Cook Medical has completed enrolment in the first clinical study of an iliofemoral venous stent conducted in the USA under an FDA-approved investigational device exemption. The VIVO clinical study is a prospective, non-randomised, multicentre study intended to evaluate the...
biolitec has announced the development of a “revolutionary, versatile and compact laser for medical application,” with the Leonardo Mini—“a space-saving, efficient, and versatile multi-functional laser,” a company press release says. The device, weighing only 900g, is available in two designs;...
Highlights: -EVAR 1 trial 15-year follow-up published: Lifelong surveillance of EVAR and prompt reintervention are paramount -IVUS may be a more accurate method than venography for assessing lesion severity and proper venous stent size -Fabio Verzini: EVAR devices -Armando Mansilha:...
Highlights: -EVAR 1 trial 15-year follow-up published: Lifelong surveillance of EVAR and prompt reintervention are paramount -IVUS may be a more accurate method than venography for assessing lesion severity and proper venous stent size -Fabio Verzini: EVAR devices -Armando Mansilha:...
These are exciting times for physicians involved in the management of venous disease. There have been important advances in basic scientific research and crucial developments in venous imaging and diagnostics. Most importantly, however, writes Manj Gohel, physicians now have...
The results of the VIRTUS feasibility study—analysing the performance of the Vici venous stent system (Veniti) in achieving patency of venous lesions up to 12 months—have recently been released, indicating that intravascular ultrasound (IVUS) may be a more accurate...
Jens Eldrup-Jorgensen has been named the new medical director of the Society for Vascular Surgery Patient Safety Organization (SVS PSO). He will replace Jack Cronenwett, who has served as medical director since 2011. The SVS PSO is a part...
The Vascular Society of Great Britain and Ireland celebrates its golden anniversary in Manchester later this month. It was initially founded by Sol Cohen as the Vascular Surgical Society in 1966 with the first two meetings held in London...
Fresh data from the VIRTUS feasibility study presented at the Vascular Interventional Advances (VIVA) annual conference 2016 (18–22 September, Las Vegas, USA) suggest that venography may underestimate the severity of venous lesions and that intravascular ultrasound (IVUS) may be...
The goal of management of venous thromboembolic disease is to prevent thrombus extension or embolisation and to prevent early and late episodes of recurrence. Armando Mansilha, Porto, Portugal, explains how our approach has changed and what obstacles still face...
Janssen Pharmaceuticals and its development partner, Bayer, announced on 23 October 2016 results of two new real-world studies confirming the positive benefit-risk profile of rivaroxaban (Xarelto) in treating venous thromboembolism, and reducing the risk of recurrence. One study showed that...
Superficial vein thrombosis (SVT) is a common disease affecting 3–11% of the general population, while in patients with varicose veins the incidence of SVT increases to as much as 60%. The prevalence of SVT appears to be two-fold higher...
Lymphoedema is a chronic, progressive condition which can often be debilitating. It is caused by a deficiency or failure of the lymphatic system. Due to its chronic nature, lymphoedema requires ongoing treatment to manage and control the swelling. It...
Ovsep Mandzhikian, Moscow, Russia, reports on his centre’s recent experience of endothermal heat-induced thrombosis following treatment with endovenous laser and radial fibres, suggesting that complications following the treatment are rare and asymptomatic. Our multicentre observational study summarises the experience of...
Veniti has closed on US$25m in Series D equity financing from Boston Scientific Corporation. The funds will allow Veniti to complete the VIRTUS trial and regulatory filing for the Vici Venous Stent system. The trial is being performed under...
Ash Verma, Clearwater, USA, writes how last year, he happened upon a routine case that struck him as both totally unremarkable and absolutely extraordinary. A 69-year-old female patient presented with one week of swelling and pain in her left...
In this special feature, Vascular News takes a look at occupational radiation—one of the most pressing concerns for vascular and endovascular professionals—speaking to several experts about the dangers of, and strategies to minimise exposure to, radiation in the operating room. http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/09/Vascular-News-71-Radiation-single-pages.pdf
Highlights: -Iliac branch device results show value of internal iliac artery revascularisation -Absorb bioresorbable scaffold yields 96% primary patency and freedom from reintervention below the knee at 12 months – In the spotlight: Radiation danger -Ragg: Biomatrix sclerofoam -Profile:...
Highlights: -Iliac branch device results show value of internal iliac artery revascularisation -Absorb bioresorbable scaffold yields 96% primary patency and freedom from reintervention below the knee at 12 months - In the spotlight: Radiation danger -Ragg: Biomatrix sclerofoam -Profile:...
Bluegrass Vascular Technologies has received CE mark approval and is launching limited commercial sale of its Surfacer Inside-Out access catheter system. The Surfacer system is indicated for obtaining central venous access to facilitate catheter insertion into the central venous...
A post-market evaluation of the VenaSeal closure system (Medtronic) has found that, at one month, 100% of treated veins remained closed, quality of life scores improved significantly, and return to work and normal activity times were short. The data...
FlowAid Medical Technologies has received CE mark approval for its FA100 SCCD sequential contraction compression device. According to a press release, the FA100 SCCD was designed with the patient in mind, intended to offer an easy to use system, allowing...
Christopher G Carsten III, Greenville Health System, Greenville, SC, USA Radiation safety practices have made tremendous advances since the discovery of Roentgen’s X-rays over 120 years ago. The sacrifices of early practitioners have led to the knowledge that now allows...
The US Food and Drug Administration (FDA) has released a draft guidance document entitled “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices”. According to an email from the consumer watchdog, the document is intended to clarify “how...
The National Institute for Health and Care Excellence (NICE) has recently issued approval via Interventional Procedure Guidance IPG557 for endovenous mechanochemical ablation for the treatment of varicose veins in the UK. The NICE guidelines provide evidence-based guidance and advice on a range...
BTG has announced that the US Food and Drug Administration (FDA) has approved an extension of the post-activation shelf life of Varithena (polidocanol injectable foam) 1% to 30 days from seven. The announcement was made on 6 July 2016. “This approval...
6 July 2016 Venous Stenting Training Day Guys and St Thomas' Hospital, London, UK http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/06/Final-Flyer-stent-course-SB-2016.pdf  
The delivery and exploration of new technology is required to reduce harmful levels of radiation during endovascular procedures, according to Edward Diethrich, a veteran cardiovascular surgeon with first-hand experience of the damage that such exposure can cause. Following many years’...
Physicians have now treated over 1,000 patients with the Vici Venous Stent. The product received CE mark in October 2013 and was first implanted in January 2014. Subsequently, it has been launched in 13 countries worldwide. Veniti says that...
Therapies in deep venous thrombosis (DVT) have been slow to advance over the past 50 years. Recently, growing awareness and improvements in tools and techniques have piqued interest in venous disease. The ATTRACT trial will try to answer the...
Highlights: -CX acknowledges “huge debt” owed to endovascular pioneers affected by radiation -Audience voting finds a place for false lumen embolisation in chronic type B dissections -Martin Bjӧrck: Iliac artery screening -Ian Franklin: Non-thrombotic iliac lesions -Profile: Wesley Moore http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/06/70-Vascular-News_US.pdf
Highlights: -CX acknowledges “huge debt” owed to endovascular pioneers affected by radiation -Audience voting finds a place for false lumen embolisation in chronic type B dissections -Martin Bjӧrck: Iliac artery screening -Ian Franklin: Non-thrombotic iliac lesions -Profile: Wesley Moore http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/06/Vascular-News-70-EU-08.pdf
The US Food and Drug Administration (FDA) has finalised its efforts to streamline the “compassionate use” process, used by physicians to access investigational drugs and biologics for patients with limited treatment options. A statement from Robert Califf, the deputy...
A new bill introduced to the US Senate by Senator Dan Coats seeks to address the gap between the US Food and Drug Administration (FDA)’s priority review process for breakthrough medical devices, and the Centers for Medical and Medicare...
The Netherlands presidency of the European Council and representatives of the European Parliament have reached a political agreement on two draft regulations for medical devices. The new regulations are aimed at ensuring that medical devices and in vitro diagnostic...
At the 2016 Charing Cross Symposium (26–29 April, London, UK) and the International Vein Congress (28–30 April, Miami, USA) Medtronic unveiled clinical data for the VenaSeal closure system demonstrating consistent long-term durability and improved quality of life in patients with venous...
Since its introduction in the late 80s, endovascular therapy has become increasingly widespread and important. A mini-symposium held at the 2016 Charing Cross Symposium (26–29 April, London, UK), brought to the fore the radiation damage that has occurred to...
In a study comparing multiplanar venography to intravascular ultrasound (IVUS) for diagnosing common or external iliac and common femoral vein stenosis, IVUS imaging was found to change both the treatment plan in 60/100 patients and the number of stents...
Two 2016 Charing Cross Symposium (CX 2016; 26–29 April, London, UK) presentations in the Venous Challenges Main Programme session have demonstrated the value of dedicated venous stents, with interim results from two studies in patients with symptomatic iliofemoral venous...
Now that non-thrombotic iliac vein lesions (NIVLs) are more frequently recognised on modern imaging modalities, they are beginning to trigger a paradigm shift in standard vein work whereby there is now increasing emphasis on making sure that these patients...
The first patient suffering from post-thrombotic syndrome associated with venous outflow obstruction has been treated with the VICI VERTO VENOUS STENT system. This stent delivery system allows the physician to deploy a venous stent beginning at the peripheral end...
A study conducted at St Thomas’ Hospital, London, UK, indicates that the VeinCLEAR catheter (RF Medical) produces good results when used in radiofrequency ablation in the treatment of lower extremity superficial venous insufficiency. The study team, led by Adam...
The Surfacer Inside-Out access catheter system (Bluegrass Vascular Technologies) has been successfully used in its first clinical case. The patient in question was facing life-threatening complications from end-stage renal disease.The procedure was performed under Germany’s "compassionate use" program, which...

“EVRF (F Care Systems) saphenous ablation is a safe and painless procedure for the treatment of the greater saphenous vein and/or small saphenous vein,” according to recently released data. The authors, led by Attila Szabo, VP-Med Health and Education Centre, Budapest, Hungary, write that “high patient acceptance and minimal postoperative discomfort allows a quick return to work and normal life for patients.”

EVRF is a monopolar radiofrequency ablation system for endothermal treatment of small, midsize and large veins. “Endovenous procedures are far less invasive than surgery and have lower complication rates,” the authors write. “The procedure is well tolerated by the patients, and it produces good cosmetic results. Excellent clinical results are seen at four to five years, and the long-term efficacy of the procedure in now known with 10 years of experience.”


Szabo and colleagues evaluated the effectiveness of EVRF treatment and analysed the three-year results of using the device for endovenous radiofrequency ablation and spider vein treatments from July 2011 to March 2015 to treat 751 saphenous reflux and varicosity patients.


Radiofrequency ablation using the EVRF CR45i catheter was performed on 751 limbs (628 greater saphenous vein, 102 small saphenous vein and 21 for both). Complete occlusion was found in 743 of 751 cases (99%) at one month. At one-year follow-up, 15 of 530 patients showed recanalisation longer than 5cm (97.2% one-year occlusion) without clinical symptoms. The three-year occlusion rate was 96.6% (two of 59 patients had an open vein segment). At one-year follow-up the investigators evaluated the postoperative pain reported by the patients on a visual analogue scale (2.4 preoperatively, 1.2, 0.4 and 0.1 at one week, one month and one year postoperatively, respectively) and Venous Clinical Severity Scores (7.7, 3.9 and 1.8 before surgery, at one month and at one year, respectively). The average patient satisfaction was 99% at one year. There were no cases of deep vein thrombosis, skin burns, neuritis or bleeding. “Minimal” bruising was observed at the treatment site of the tributaries in some cases and four patients had mild inflammation which was treated conventionally.


For smaller veins, more than 5,000 treatment sessions for teleangiectasias and spider veins on the face and lower limbs were completed. The authors used radiofrequency treatment or combined the treatment with liquid sclerotherapy. Facial recovery rate was 100% and lower limb recovery rate was 82% on average. The treatments were “well tolerated—although the pain level always depends on the patients’ current psychic status—and the patient satisfaction rate was high,” the authors report.


Szabo and colleagues suggest that “EVRF is appropriate for the treatment of teleangiectasias, reticular veins with the hand piece and K3i or K6i needles (face or lower leg), small varicose veins or tributaries 2–5mm with the hand catheters and for saphenous truncs and perforators 4–15mm in diameter with the CR45i catheter.”


“The procedure, under local tumescent anaesthesia, is simple and the disposable devices are easy to use. The EVRF hand piece with K3i and K6i needles proved to be useful in teleangiectasia treatment, with excellent results,” Szabo et al conclude. “This radiofrequency procedure is also suitable for combination with liquid or foam sclerotherapy.”

Boehringer Ingelheim has announced the enrolment of the first patient in RE-COVERY DVT/PE, a global observational study on the management of deep vein thrombosis (DVT) and pulmonary embolism (PE). “Large pivotal randomised trials have revolutionised our strategies to manage and...
The US Food and Drug Administration has announced a proposal to ban most powdered gloves in the USA. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care...
Highlights: -Tackling the challenges in the vascular and endovascular arena -CX Venous Workshop -CX Vascular Access course -CX Edited Live Cases -CX ilegx Collaboration Day -CX Acute Stroke Challenges Programme -Summary of Vascular News and Interventional News profiles 2015 http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/03/VNCharingCross2016US_lowres.pdf
Highlights: -Tackling the challenges in the vascular and endovascular arena -CX Venous Workshop -CX Vascular Access course -CX Edited Live Cases -CX ilegx Collaboration Day -CX Acute Stroke Challenges Programme -Summary of Vascular News and Interventional News profiles 2015 http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/03/VNCharingCross2016EU_lowres.pdf
Hybrid operative thrombectomy achieves complete thrombus resolution in one operating room trip which results in reduced length of stay, bleeding complications and transfusions when compared with percutaneous treatments that use thrombolytic therapy. This can be achieved without sacrificing successful...
A few months ago a discussion on the LinkedIn page of the American College of Phlebology caught my attention: “Medicare: maximum four endovenous laser 
therapies per lifetime?” In Belgium we can use one radiofrequency catheter or endovenous laser ablation fibre...
According to the World Health Organization, around 300 million people are affected by the pathological oedema of limbs. Lymphoedema is caused by partial or total obstruction of lymphatic collectors as a consequence of skin and deep soft tissue inflammation,...
Saphenous pulsation is the cyclical impulse of antegrade flow observed on colour duplex ultrasound after prolonged standing. It is a common observation in patients with saphenous reflux and is detected in the upper part of the great saphenous vein,...
AngioDynamics has signed an agreement with Merz North America, a US affiliate of the global Merz Pharma Group, to serve as the exclusive distributor of Asclera (polidocanol) injection within the US vein market. Asclera is approved for the treatment of uncomplicated spider and uncomplicated...
At the 2016 Leipzig Interventional Course meeting (LINC; 26–29 January, Leipzig, Germany), Michael R Jaff, Boston, USA, discussed the challenges facing intervention for deep vein thrombosis and pulmonary embolism, and when using an interventional approach may be preferable. “When you...
The US Food and Drug Administration (FDA) has confirmed the appointment of Robert Califf as its 22nd commissioner, following a US Senate vote of 88 to 4 in his favour. Califf was nominated to replace previous commissioner, Margeret A Hamburg, by...
ArtVentive Medical has announced enrolment in the ongoing OCCLUDE post-market surveillance study. This study aims to further the use of the EOS endoluminal occlusion system for the treatment of venous and arterial cases in which precise placement and immediate,...
Highlights: -Neuromonitoring changes trigger protocol against spinal cord ischaemia during TEVAR -New European industry code: Sponsorship of physicians to attend congresses to be done via healthcare organisations -In the spotlight: Atherectomy -Raphaël Coscas: Vascular access -Profile: Jonathan Beard http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/69-Vascular-News_US.pdf
Huntleigh has launched the Dopplex DMX digital vascular Doppler. According to a company release, this Doppler combines audio clarity and a visual representation of waveforms with high performance probe sensitivity.
Cook Medical has initiated a voluntary recall of 360 specific lots of single lumen central venous catheters and pressure monitoring sets and trays due to catheter tip fracture and/or separation. Globally, 17,827 devices are subject to this recall.
The kit comprises the company's DMX Doppler, probes and accessories to aid the vascular, diabetic or lymphatic specialist with the assessment of arterial disease and neuropathy.
Highlights: -Neuromonitoring changes trigger protocol against spinal cord ischaemia during TEVAR -New European industry code: Sponsorship of physicians to attend congresses to be done via healthcare organisations -In the spotlight: Atherectomy -Raphaël Coscas: Vascular access -Profile: Jonathan Beard http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/69-Vascular-News_EU.pdf  
Rick De Graaf, Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands, presented the results of the first comparative study of four dedicated stents for the venous system at the VEITHsymposium (17–20 November 2015, New York, USA). De...
Researchers have activated the first 10 medical sites and enrolled the first nine patients in a study that will determine the safety and effectiveness of inferior vena cava filters, small, cage-like devices implanted to prevent life-threatening blood clots from...
Bristol-Myers Squibb and Pfizer have announced results from a post-hoc early time course subanalysis of the phase 3 AMPLIFY (Apixaban for the initial management of pulmonary embolism and deep vein thrombosis as first-line therapy) trial. The subanalysis demonstrated Eliquis (apixaban) was comparable to...
Bayer and its development partner Janssen Pharmaceuticals presented results from two real world studies—the non-interventional XALIA study in patients with deep vein thrombosis (DVT) and a study looking at patients with cancer-associated thrombosis on 8 December 2015. Results from...
The European Diagnostics Manufacturers Association (EDMA) and the European Medical Technology Industry (Eucomed) have approved a new joint code of conduct that stipulates that, after 31 December 2017, industry should no longer provide direct “financial or in kind support”...
Highlights: -IN.PACT SFA two-year results "have potential to drive paradigm shift" in femoropopliteal lesion treatment -PERICLES study helps bring chimney technique "out of the shadows" -Endologix and TriVascular announce merger -Jeffrey P Carpenter: Protection devices -Peter H Lin: Thrombolysis...
Highlights: -IN.PACT SFA two-year results "have potential to drive paradigm shift" in femoropopliteal lesion treatment -PERICLES study helps bring chimney technique "out of the shadows" -Endologix and TriVascular announce merger -Jeffrey P Carpenter: Protection devices -Peter H Lin: Thrombolysis...
By Athanasios D Giannoukas Today, venous stenting plays an important role in the treatment of deep venous pathologies. The current indications for its use include acute iliofemoral thrombosis after catheter-directed or pharmacomechanical thrombolysis to resolve residual iliac stenosis, May-Thurner syndrome and...
According to new a study published in PLOS Medicine, a new clinical model can help predict the risk of venous thromboembolism (VTE) among patients with a leg case, enabling doctors to identify high risk cases. Using data from three large cohorts,...
Medtronic’s VenaSeal closure system has been granted pre-market approval (PMA) from the US Food and Drug Administration (FDA) for the treatment of symptomatic venous reflux. This minimally invasive procedure is the first and only non-tumescent, non-thermal, non-sclerosant procedure approved for...
Peter H Lin   Pulmonary embolism in children is a potentially lethal condition and yet is a vastly understudied arena. Autopsy studies show a higher prevalence of pulmonary embolism compared to medical database registries suggesting that this condition is often clinically...
Highlights: -"Working with radiation is like keeping a pet tiger in your living room" -Wearable exercise tracker improves intermittent claudication symptoms at six months -Endovascular revolution in the aorta: 25 years of a landmark case -Profile: Sebastian Debus -Rabih...
Highlights: -"Working with radiation is like keeping a pet tiger in your living room" -Wearable exercise tracker improves intermittent claudication symptoms at six months -Endovascular revolution in the aorta: 25 years of a landmark case -Profile: Sebastian Debus -Rabih...
At procedure, Zilver Vena stent placement resulted in a more than two-fold improvement in the vessel minimum lumen diameter. Based on available follow-up data, stent placement has corresponded to improved clinical symptoms.
The City University of New York (CUNY), Lawrence Livermore National Laboratory, and Near Infrared Imaging, have released the “Vein-Eye” camera. The Vein-Eye provides enhanced visualisation of veins when drawing blood or placing IVs in a patient’s arm or hand....
By Johann Chris Ragg  Patients with saphenous insufficiency can undergo valve zone shaping instead of destructive methods by surgical removal or endovenous closure, says Johann Chris Ragg. He presented the new vein restoring modality at the European Venous Forum (EVF;...
Dedicated venous stents can be effectively used to relieve outflow obstruction at one year following thrombotic disease in both the acute and chronic setting, according to the prize-winning research presented at the European Venous Forum (EVF; 2–4 July, Saint...
The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has recommended a new treatment to help patients suffering from blood clots in the legs and lungs.NICE has issued its final recommendation...
The study concluded that treatment with ultrasound-facilitated catheter-directed low-dose thrombolysis for acute pulmonary embolism improves right heart function, reduces blood clot size, and decreases pulmonary hypertension in patients with intermediate to high risk pulmonary embolism.
The first patient has been enrolled in ETNA-AF-Europe (Edoxaban treatment in routine clinical practice – atrial fibrillation – Europe), and ETNA-VTE-Europe (Edoxaban treatment in routine clinical practice – venous thromboembolism – Europe) has commenced. Daiichi Sankyo’s European ETNA registries are...
Results of the landmark CATCH (Comparison of Acute Treatments in Cancer Haemostasis) study were published in The Journal of American Medical Association (JAMA), comparing innohep (tinzaparin), a low-molecular weight heparin (LMWH), with warfarin in patients with cancer-associated thrombosis. In the study, sponsored by...
BTG announced on 6 August 2015 that Health Canada has issued a notice of compliance approving polidocanol injectable foam (Varithena, BTG) for the treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous...
By Samuel Money Open vena caval surgery is rare. It is mainly performed for oncological indications when the inferior vena cava is involved by an adjacent tumour. One of the most common malignancies that affect the inferior vena cava is...
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX...
After the European launch in April 2015, Biolas has introduced the VariClose Vein Sealing Systems in the European market for the treatment of varicose veins.
NICE has issued a Final Appraisal Determination (FAD) for Lixiana (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults.
BioGlue is now indicated for adhesion and support of haemostasis for aortotomy closure sites, suture/anastomosis sites (including aortic dissection and anastomosis sites with a prosthetic graft), and suture sites on the heart.
The 12-month closure rates for Medtronic's VenaSeal closure system are comparable to those achieved using radiofrequency ablation.
Twelve-month results from the VeClose trial have demonstrated cyanoacrylate adhesive (CAE) is non-inferior to radiofrequency ablation (RFA) for the treatment of incompetent great saphenous veins.
Highlights: -One-year IMPROVE data suggest benefit of EVAR in ruptured aneurysms -New Eluvia drug-eluting stent shows 94.4% primary patency rate at nine months -Michael Dake: Arch branded device -Andrew Holden: Bioresorbable stents -Profile: Janet Powell http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/66-Vascular-News-USA.pdf  
Highlights: -One-year IMPROVE data suggest benefit of EVAR in ruptured aneurysms -New Eluvia drug-eluting stent shows 94.4% primary patency rate at nine months -Michael Dake: Arch branded device -Andrew Holden: Bioresorbable stents -Profile: Janet Powell http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/66-Vascular-News-EU.pdf  
Jan Heyligers and Patrick Vriens, Tilburg, The Netherlands, write about a technique using the great saphenous vein for the reconstruction of an infected aorta. The technique, defined as a “see one, do one” procedure, was presented at the Charing...
The decision provides supplemental reimbursement to US hospitals for the new medical device with the potential to improve outcomes for patients undergoing a percutaneous transthoracic lung biopsy.
Bristol-Myers Squibb and Pfizer have announced that the National Institute for Health and Care Excellence (NICE) has published final guidance recommending the use of Eliquis (apixaban) as an option for the treatment of deep vein thrombosis (DVT) and pulmonary...
As part of a 90-day implementation plan, the NHS now has three months for apixaban to be made available to patients in England and Wales whose doctors believe it is a clinically appropriate treatment for them.
This video tells the story of one of the world’s most prominent heart surgeons, Edward Diethrich, and the career-altering health issues he has faced as a result of chronic, low-level exposure to ionising radiation through his work. https://youtu.be/rXgt0bF3GJM
Highlights: -Discussion of controversies tops Charing Cross 2015 agenda -CX Venous Workshop -CX Live Peripheral Arterial Cases -CX Edited Live Cases -CX ilegx Collaboration Day -Summary of Vascular News and Interventional News profiles 2014 http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/CX-Vascular-News-2015-US_low-res.pdf
The second day of the CX Venous Workshop was held yesterday on the Upper Level of the Gallery, rounding off a busy week in which more than 950 people visited over the two days—a new record for the Workshop....
Yesterday saw the beginning of the two-day CX Venous Workshop, in which delegates can enjoy expert demonstrations of a selection of the most interesting and important phlebological technologies currently in use. Now in its seventh year, the event continues...
Observational studies show a sharp increase in the placement of inferior vena cava filters over the past three decades, including their use as add-on therapy to anticoagulant therapy in patients presenting with a blood clot.
Daiichi Sankyo has announced that Swissmedic, the regulatory authority of Switzerland, has granted approval of Lixiana (edoxaban), an oral, once-daily selective factor Xa inhibitor, for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation. Simultaneously,...
Early data from a multicentre, single-arm study that set out to evaluate the safety and effectiveness of a novel approach to inferior vena cava filtration using the VenaTech convertible filter (B Braun Interventional Systems) suggest that the use of...
Intrinsic Imaging has been awarded a clinical trial to study an interventional medical device designed for the prevention of pulmonary emboli. Throughout this trial, Intrinsic Imaging will provide imaging core lab services including, but not limited to, protocol and charter...
Highlights: -Discussion of controversies tops Charing Cross 2015 agenda -CX Venous Workshop -CX Live Peripheral Arterial Cases -CX Edited Live Cases -CX ilegx Collaboration Day -Summary of Vascular News and Interventional News profiles 2014 http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/CX-Vascular-News-2015-EU_low-res.pdf
The Medtronic VenaSeal system is intended for patients with symptomatic superficial varicose veins of the legs.
biolas has announced the launch of its VariClose vein sealing systems in Europe. VariClose is a new technique by which an incompetent saphenous vein is sealed through embolization. biolas says that the procedure is simpler and more successful than older...
Medtronic announced today that a previously communicated global voluntary recall to address an issue with certain lots of its Trellis-6 and Trellis-8 peripheral infusion systems has now been classified as a Class 1 recall by the US Food and...
The US Food and Drug Administration (FDA) has approved Daiichi Sankyo’s Savaysa (edoxaban), an oral, once-daily selective factor Xa inhibitor, to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. In ENGAGE AF-TIMI 48, Savaysa...
Highlights: -Publishing individual outcome data way make physicians risk averse -Early results suggest Lithoplasty is effective in the treatment of calcified lesions -SPACE 2 cartoid study is halted -Juan Perodi: A humble patient -Rocha-Singh: DEBs below-the-knee -Profile: Jean-Baptiste Ricco http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/65-Vascular-News-US_low-res-1.pdf
Highlights: -Publishing individual outcome data way make physicians risk averse -Early results suggest Lithoplasty is effective in the treatment of calcified lesions -SPACE 2 cartoid study is halted -Juan Perodi: A humble patient -Rocha-Singh: DEBs below-the-knee -Profile: Jean-Baptiste Ricco http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/65-Vascular-News-EU_low-res.pdf